|
|
|
Viral Vaccines & Therapeutics
Complex Emerging Technologies
Development and cGMP Manufacturing of Viral Vaccines & Therapeutics
SAFC Pharma provides over 10 years experience in manufacturing viral vectors and vaccines with highly trained personnel and state-of-the-art facilities. Recently announced, the expanded analytical and manufacturing capabilities now support customers from pre-clinical to commercial-scale quantities.
| Our Offer |
| |
Process development |
| |
cGMP manufacturing of clinical drug and commercial products |
| |
Final fill/finish |
| |
Regulatory compliance services |
| Vaccines Development & Manufacturing |
| |
Vaccines have undergone a renaissance in the past decade as new manufacturing techniques and new indications have spurred investment into next-generation candidates. SAFC Pharma has experience working with small and large biotechs for such indications as influenza, pandemic flu, AIDS, malaria and other vaccines. |
| Therapeutics Development & Manufacturing |
| |
While most indications now revolve around oncology, SAFC Pharma has supported gene therapy clients for over 10 years and products for all major viral vector systems and many clinical trials. |
| Service Offering Examples |
| |
cGMP Viral Bulk Drug Substance Manufacturing |
| |
cGMP Cell and Viral Banking |
| |
Sterile Fill and Finish |
| |
Secure Biostorage |
| |
Containment facility |
| |
Access to fully characterized 293-clonal cell line (AC2) |
| |
Access to PER.C6™ cell line* |
| QC and Analytical Services |
SAFC Pharma provides customers with complete support, including the development of specifications, risk assessment, implementation of process controls and qualified disinfectant cleaning procedures.
In addition to our state-of-the-art PCR facility we offer: |
| |
Phase-specific analytical development |
| |
Characterization, certification and control of all incoming raw materials |
| |
QC testing of in-process materials |
| |
Release testing as requested |
| |
Stability studies |
With extensive experience in process development, our chemists prepare bench-scale processes for development to Phase I production using capabilities in: |
| |
Vector construction |
| |
Characterization studies |
| |
Media development (through respected sister company, SAFC Biosciences™) |
| Traditional or Disposable Bioreactor Selection |
| |
Wave |
| |
Single Use Bioreactor (SUB) |
| |
Upstream and downstream process improvements that can increase yield |
| |
Stir-Tank |
| |
Shake Flasks |
| Quality Management |
| |
Independent Quality Assurance (QA) unit |
| |
Highly experienced staff |
| |
Clinical product successfully manufactured for trials in US, EU and Asia |
| |
Rigorous compliance program |
| Project Management |
| |
SAFC's Project Managers lead multi-functional teams in support of custom cGMP projects and serve as single-point-of-contact for customers to facilitate timely communication of important technical information and production timelines. |
|
|
* PER.C6 cells are manufactured under license to Crucell, N.V. Commercial clients must have a separate research and/or commercial license from Crucell, N.V. PER.C6 cells are available for academic and governmental clients through payment of project specific access fees.
|
|